Pfizer (Japan)

683 papers and 12.2k indexed citations i.

About

In recent decades, authors affiliated with Pfizer (Japan) have published 683 papers, which have received a total of 12.2k indexed citations. Scholars at this organization have produced 151 papers in Molecular Biology, 118 papers in Oncology and 100 papers in Pharmacology on the topics of Rheumatoid Arthritis Research and Therapies (53 papers), Chronic Lymphocytic Leukemia Research (41 papers) and Pain Mechanisms and Treatments (35 papers). Their work is cited by papers focused on Molecular Biology (3.0k citations), Oncology (2.0k citations) and Pharmacology (1.6k citations). Authors at Pfizer (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Journal of the American Chemical Society, Journal of Biological Chemistry and Circulation. Some of Pfizer (Japan)'s most productive authors include Yoshiko Umeyama, Ikuo Horii, Satomi Onoue, Yoshiya Tanaka and Naonobu Sugiyama.

In The Last Decade

Fields of papers published by authors at Pfizer (Japan)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Pfizer (Japan) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Pfizer (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pfizer (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pfizer (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pfizer (Japan) more than expected).

Rankless by CCL
2025